Longitudinal characterization of [18F]-FDG and [18F]-AV45 uptake in the double transgenic TASTPM mouse model

Manuscript Number: 

16-0760R1

Author(s): 
Xavier Langlois, Jill Richardson, Mark Schmidt, Steven Staelens, Sigrid Stroobants, Jeroen Verhaeghe, Ann-Marie Waldron, Leonie wyffels

Disclosures

Xavier Langlois

  • Equity:
    I own JNJ stocks
    Sponsors:
    Scientific director

Jill Richardson

  • Equity:
    I am a full time employed of GlaxoSmithKline. GSK did not sponsor the study directly.

Mark Schmidt

  • Equity:
    Equity in Johnson & Johnson in the form of share, and stock options Stocks in a variety of other companies as investments, but JNJ is the most relevant to this mss as the sponsor of the study.
    Sponsors:
    Full time employment as a Senior Director in Janssen R&D, working as a senior clinical scientist in Neuroscience/Experimental Medicine

Steven Staelens

  • Nothing to Disclose

Sigrid Stroobants

  • Nothing to Disclose

Jeroen Verhaeghe

  • Nothing to Disclose

Ann-Marie Waldron

  • Nothing to Disclose

Leonie wyffels

  • Nothing to Disclose